SCHEMBL6965693

SCHEMBL6965693

COc1ccc(-c2cc(O)c(SCc3ccccc3)c(=O)o2)c(OC)c1OC

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ELANE P08246 1/20 0.42
HDAC4 P56524 1/20 0.42
HDAC2 Q92769 1/20 0.42
HDAC8 Q9BY41 1/20 0.42
PIK3CG P48736 1/20 0.41
QPCT Q16769 1/20 0.39
ALDH1A1 P00352 4/20 0.38
HTT P42858 2/20 0.38
KDM4E B2RXH2 1/20 0.38
POLB P06746 1/20 0.38
GAA P10253 1/20 0.38
EGFR P00533 2/20 0.38
CYP3A4 P08684 1/20 0.38
PTGES O14684 1/20 0.37
ACHE P22303 1/20 0.36
PLK1 P53350 1/20 0.36
BACE1 P56817 1/20 0.36
ALOX5 P09917 1/20 0.36
RAB9A P51151 3/20 0.36
NPC1 O15118 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6960147 0.85 ALOX5 (0.53) ELANEPIK3CGALDH1A1KDM4EPOLB
SCHEMBL6964365 0.81 PTGES (0.47) ELANEPIK3CGALDH1A1KDM4EPOLB
SCHEMBL6958241 0.80 MAOB (0.46) ELANEPIK3CGALDH1A1KDM4EPOLB
SCHEMBL6956094 0.79 AKR1C3 (0.46) ELANEALDH1A1KDM4EEGFRCYP3A4
SCHEMBL6958994 0.78 HPGD (0.45) ELANEALDH1A1KDM4EEGFRRAB9A
SCHEMBL6958649 0.78 NTRK1 (0.51) PIK3CGALDH1A1KDM4EEGFRCYP3A4
SCHEMBL6954786 0.76 SMN1; SMN2 (0.50) ELANEHDAC8ALDH1A1KDM4EPOLB
SCHEMBL6961428 0.76 MEN1 (0.45) ALDH1A1HTTKDM4EPOLBGAA
SCHEMBL6965060 0.76 CYP3A4 (0.46) HDAC4HDAC8PIK3CGALDH1A1KDM4E
SCHEMBL6956208 0.76 NTRK1 (0.48) ALDH1A1KDM4EPOLBCYP3A4ACHE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5808062-A AIDS THERAPY WARNER-LAMBERT COMPANY (US) 1998-09-15 US claimed
EP-0729466-A1 PYRONE DERIVATIVES AS PROTEASE INHIBITORS AND ANTIVIRAL AGENTS PARKE, DAVIS & COMPANY (US) 1996-09-04 EP claimed
WO-1995014014-A2 PYRONE DERIVATIVES AS PROTEASE INHIBITORS AND ANTIVIRAL AGENTS PARKE, DAVIS & COMPANY (US) 1995-05-26 WO claimed
EP-0729465-B1 PYRONE DERIVATIVES AS PROTEASE INHIBITORS AND ANTIVIRAL AGENTS PARKE DAVIS & CO (US) 2003-01-22 EP disclosed
US-6005103-A TREATMENT OF BACTERIAL AND VIRAL INFECTIONS AND DISEASES, INCLUDING AIDS WARNER-LAMBERT COMPANY (US) 1999-12-21 US disclosed
US-5808062-A AIDS THERAPY WARNER-LAMBERT COMPANY (US) 1998-09-15 US disclosed
EP-0729465-A1 PYRONE DERIVATIVES AS PROTEASE INHIBITORS AND ANTIVIRAL AGENTS PARKE, DAVIS & COMPANY (US) 1996-09-04 EP disclosed
EP-0729466-A1 PYRONE DERIVATIVES AS PROTEASE INHIBITORS AND ANTIVIRAL AGENTS PARKE, DAVIS & COMPANY (US) 1996-09-04 EP disclosed
WO-1995014013-A1 PYRONE DERIVATIVES AS PROTEASE INHIBITORS AND ANTIVIRAL AGENTS PARKE, DAVIS & COMPANY (US) 1995-05-26 WO disclosed
WO-1995014014-A2 PYRONE DERIVATIVES AS PROTEASE INHIBITORS AND ANTIVIRAL AGENTS PARKE, DAVIS & COMPANY (US) 1995-05-26 WO disclosed